News & Events category:
Saint Mary's Hospital

Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.

The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder.

ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.

A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.

An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.

MFT, Research and Innovation colleagues mark 75 years of the National Health Service (NHS).

Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.

University of Manchester Chancellor Nazir Afzal OBE has become the 1,000th person in Greater Manchester to take part in a huge research project.